Fetal transfusion for red blood cell alloimmunization in pregnancy

Obstetrics and Gynecology

Volumn 88, Issue 1, 1996, Pages 137-150

  Schumacher, Bernd ^a   Moise Jr , Kenneth J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ANEMIA; DATA ANALYSIS; DATA BASE; ERYTHROCYTE TRANSFUSION; FETUS; FETUS HYDROPS; FETUS MATURITY; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MEDICAL RECORD; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029973514     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00113-5     Document Type: Review

References (161)

1. Bowman JM. Hemolytic disease (erythroblastosis fetalis). In: Creasy RK, Resnik R, eds. Maternal-fetal medicine: Principles and practice. 3rd ed. Philadelphia: WB Saunders, 1994:711-43.
2. American College of Obstetricians and Gynecologists. Prevention of D isoimmunization. ACOG Technical Bulletin no. 147. Washington, DC: American College of Obstetricians and Gynecologists, 1990.
3. Chavez GF, Mulinare J, Edmonds LD. Epidemiology of Rh hemolytic disease of the newborn in the United States. JAMA 1991;265:3270-4.
4. Moise KJ, Milam JD, Carpenter KJ. Changing trends in the diagnosis and treatment of Rh alloimmunization. Tex Med 1987; 83:27-32.
5. Moise KJ. Changing trends in the management of red blood cell alloimmunization in pregnancy. Arch Pathol Lab Med 1994;118: 421-8.
6. Moise KJ. Management of red cell alloimmunization in pregnancy. In: Sacher RA, Brecher ME, eds. Obstetric transfusion practice. Bethesda, Maryland: American Association of Blood Banks, 1993:21-47.
7. Moise KJ. Intrauterine transfusion with red cells and platelets. West J Med 1993;159:318-24.
8. Harman CR. Invasive techniques in the management of alloimmune anemia. In: Harman CR, ed. Invasive fetal testing and treatment. Boston: Blackwell Scientific Publications, 1995:107-91.
9. Bennett PR, Le Van Kim C, Colin Y, Warwick RM, Cherif-Zahar B, Fisk NM, et al. Prenatal determination of fetal RhD type by DNA amplification following chorion villus biopsy or amniocentesis. N Engl J Med 1993;329:607-10.
10. Spence WC, Potter P, Maddalena A, Demers DB, Bick DP. DNA-based prenatal determination of the RhEe genotype. Obstet Gynecol 1995;86:670-2.
11. Nicolaides KH, Rodeck CH, Mibashan RS, Kemp JR. Have Liley charts outlived their usefulness? Am J Obstet Gynecol 1986;155: 90-4.
12. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Grant SS, Widness JA. Management of fetal hemolytic disease by cordocentesis: I. Prediction of fetal anemia. Am J Obstet Gynecol 1991;165: 546-53.
13. Queenan JT, Tomai TP, Ural SH, King JC. Deviation in the amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: A proposal for clinical management. Am J Obstet Gynecol 1993;168: 1370-6.
14. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239-44.
15. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
16. 450 value in amniotic fluid. Obstet Gynecol 1982;60:746-9.
17. Barss VA, Benacerraf BR, Greene MF, Phillippe M, Frigoletto FD. Sonographic detection of fetal hydrops. J Reprod Med 1985;30: 893-4.
18. Green GH. Historic perspective on Liley's 'fetal transfusion.' Vox Sang 1985;48:184-7.
19. Green GH. William Liley and fetal transfusion: A perspective in fetal medicine. Fetal Ther 1986;1:18-22.
20. Liley AW. Intrauterine transfusion of foetus in haemolytic disease. BMJ 1963;2:1107-9.
21. Liley AW. The development of the idea of fetal transfusion. Am J Obstet Gynecol 1971;111:303-4.
22. Halitsky V, Krumholz BA, Schwalb E, Gromisch DS. The current role of intrauterine fetal transfusion in the management of erythroblastosis fetalis. Obstet Gynecol Surv 1968;23:301-30.
23. Queenan JT. Fetal transfusion. Fetal Ther 1986;1:59-64.
24. Asensio SH, Figueroa-Longo JG, Pelegrina IA. Intrauterine exchange transfusion. Am J Obstet Gynecol 1966;95:1129-33.
25. Asensio SH, Figueroa-Longo JG, Pelegrina IA. Intrauterine exchange transfusion: A new technique. Obstet Gynecol 1968;32: 350-5.
26. Freda VJ, Adamsons K. Exchange transfusion in utero: Report of a case. Am J Obstet Gynecol 1964;89:817-21.
27. Seelen J, Van Kessel H, Van Leusden H, Eskes T, Been J, Evers J, et al. A new method of exchange transfusion in utero: Cannulation of vessels on the fetal side of the human placenta. Am J Obstet Gynecol 1966;95:872-6.
28. Cherry SH. An abdominal grid for intrauterine transfusions. Obstet Gynecol 1967;30:881-2.
29. Krumholz BA, Halitsky V. A grid and isometric rulers for accurate needle placement during intrauterine transfusion. Obstet Gynecol 1968;32:706-12.
30. Bowman JM. The management of Rh-isoimmunization. Obstet Gynecol 1978;52:1-16.
31. Frigoletto FD, Umansky I, Birnholz J, Acker D, Easterday CL, Harris GB, et al. Intrauterine fetal transfusion in 365 fetuses during fifteen years. Am J Obstet Gynecol 1981;139:781-90.
32. Cooperberg PL, Carpenter CW. Ultrasound as an aid in intrauterine transfusion. Am J Obstet Gynecol 1977;128:239-41.
33. Frigoletto FD, Birnholz JC, Rothchild SB, Finberg HJ, Umansky I. Intrauterine transfusion with the use of phased array ultrasonography: A new technique. Am J Obstet Gynecol 1978;131:273-5.
34. Platt LD, Keegan KA, Druzin ML, Gauthier RJ, Evertson LR, Manning FA. Intrauterine transfusion utilizing linear-array, realtime B scan: A preliminary report. Am J Obstet Gynecol 1979;135: 1115-6.
35. Bowman JM, Manning FA. Intrauterine fetal transfusions: Winnipeg 1982. Obstet Gynecol 1983;61:203-9.
36. Rodeck CH, Kemp JR, Holman CA, Whitmore DN, Karnicki J, Austin MA. Direct intravascular fetal blood transfusion by fetoscopy in severe rhesus isoimmunisation. Lancet 1981;i:625-7.
37. Bang J, Bock JE, Trolle D. Ultrasound-guided fetal intravenous transfusion for severe rhesus haemolytic disease. BMJ 1982;284: 373-4.
38. MacKenzie IZ, Bowell PJ, Ferguson J, Castle BM, Entwistle CC. In-utero intravascular transfusion of the fetus for the management of severe rhesus isoimmunization - A reappraisal. Br J Obstet Gynaecol 1987;94:1068-73.
39. MacKenzie IZ, MacLean DA, Fry A, Evans SL. Midtrimester intrauterine exchange transfusion of the fetus. Am J Obstet Gynecol 1982;143:555-9.
40. Rodeck CH, Nicolaides KH, Warsof SL, Fysh WJ, Gamsu HR, Kemp JR. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. Am J Obstet Gynecol 1984; 150:769-74.
41. Berkowitz RL, Chitkara U, Goldberg JD, Wilkins I, Chervenak FA, Lynch L. Intrauterine intravascular transfusions for severe red blood cell isoimmunization: Ultrasound-guided percutaneous approach. Am J Obstet Gynecol 1986;155:574-81.
42. Berkowitz RL, Chitkara U, Wilkins I, Lynch L, Mehalek KE. Technical aspects of intravascular intrauterine transfusions: Lessons learned from thirty-three procedures. Am J Obstet Gynecol 1987;157:4-9.
43. Christmas JT, Little BB, Johnston WL, Santos-Ramos R, Theriot SK, Brown CEL. Nomograms for rapid estimation of intravascular intrauterine exchange transfusion. Obstet Gynecol 1990;75: 887-91.
44. Grannum PA, Copel JA, Plaxe SC, Scioscia AL, Hobbins JC. In utero exchange transfusion by direct intravascular injection in severe erythroblastosis fetalis. N Engl J Med 1986;314:1431-4.
45. Lewis M, Bowman JM, Pollock J, Lowen B. Absorption of red cells from the peritoneal cavity of an hydropic twin. Transfusion 1973;13:37-40.
46. Creasman WT, Duggan FR, Lund CJ. Absorption of transfused chromium-labeled erythrocytes from the fetal peritoneal cavity in hydrops fetalis. Am J Obstet Gynecol 1966;94:586-8.
47. Taylor WW, Scott DE, Pritchard JA. Fate of compatible adult erythrocytes in the fetal peritoneal cavity. Obstet Gynecol 1966; 28:175-81.
48. Harman CR, Bowman JM, Manning FA, Menticoglou SM. Intrauterine transfusion - Intraperitoneal versus intravascular approach: A case-control comparison. Am J Obstet Gynecol 1990; 162:1053-9.
49. Dildy GA, Smith LG, Moise KJ, Cano LE, Hesketh DE. Porencephalic cyst: A complication of fetal intravascular transfusion. Am J Obstet Gynecol 1991;165:76-8.
50. Moise KJ, Carpenter RJ, Huhta JC, Deter RL. Umbilical cord hematoma secondary to in utero intravascular transfusion for Rh isoimmunization. Fetal Ther 1987;2:65-70.
51. Seeds JW, Chescheir NC, Bowes WA, Owl-Smith FA. Fetal death as a complication of intrauterine intravascular transfusion. Obstet Gynecol 1989;74:461-3.
52. Moise KJ, Carpenter RJ, Kirshon B, Deter RL, Sala JD, Cano LE. Comparison of four types of intrauterine transfusion: Effect on fetal hematocrit. Fetal Ther 1989;4:126-37.
53. Nicolini U, Kochenour NK, Greco P, Letsky E, Rodeck CH. When to perform the next intra-uterine transfusion in patients with Rh allo-immunization: Combined intravascular and intraperitoneal transfusion allows longer intervals. Fetal Ther 1989;4:14-20.
54. Santolaya J, Warsof SL. Combined intravascular-intraperitoneal transfusions in hydropic twins due to Rh (D) alloimmunization. Fetal Diagn Ther 1990;5:70-5.
55. Ch de Crespigny L, Robinson HP, Quinn M, Doyle L, Ross A, Cauchi M. Ultrasound-guided fetal blood transfusion for severe rhesus isoimmunization. Obstet Gynecol 1985;66:529-32.
56. Nicolini U, Nicolaidis P, Fisk NM, Tannirandorn Y, Rodeck CH. Fetal blood sampling from the intrahepatic vein: Analysis of safety and clinical experience with 214 procedures. Obstet Gynecol 1990;76:47-53.
57. Nicolini U, Santolaya J, Ojo OE, Fisk NM, Hubinont C, Tonge M, et al. The fetal intrahepatic umbilical vein as an alternative to cord needling for prenatal diagnosis and therapy. Prenat Diagn 1988; 8:665-71.
58. Benacerraf BR, Barss VA, Saltzman DH, Greene MF, Penso CA, Frigoletto FD. Acute fetal distress associated with percutaneous umbilical blood sampling. Am J Obstet Gynecol 1987;156:1218-20.
59. Westgren M, Selbing A, Stangenberg M. Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation. BMJ 1988;296:885-6.
60. Plecas DV, Chitkara U, Berkowitz GS, Lapinski RH, Alvarez M, Berkowitz RL. Intrauterine intravascular transfusion for severe erythroblastosis fetalis: How much to transfuse? Obstet Gynecol 1990;75:965-9.
61. Welch R, Rampling MW, Anwar A, Talbert DG, Rodeck CH. Changes in hemorheology with fetal intravascular transfusion. Am J Obstet Gynecol 1994;170:726-32.
62. Nicolaides KH, Thilaganathan B, Mibashan RS. Cordocentesis in the investigation of fetal erythropoiesis. Am J Obstet Gynecol 1989;161:1197-200.
63. Mandelbrot L, Daffos F, Forestier F, MacAleese J, Descombey D. Assessment of fetal blood volume for computer-assisted management of in utero transfusion. Fetal Ther 1988;3:60-6.
64. Leduc L, Moise KJ, Carpenter RJ, Cano LE. Fetoplacental blood volume estimation in pregnancies with Rh alloimmunization. Fetal Diagn Ther 1990;5:138-46.
65. Weiner CP, Pelzer GD, Heilskov J, Wenstrom KD, Williamson RA. The effect of intravascular transfusion on umbilical venous pressure in anemic fetuses with and without hydrops. Am J Obstet Gynecol 1989;161:1498-501.
66. Hallak M, Moise KJ, Hesketh DE, Cano LE, Carpenter RJ. Intravascular transfusion of fetuses with rhesus incompatibility: Prediction of fetal outcome by changes in umbilical venous pressure. Obstet Gynecol 1992;80:286-90.
67. Radunovic N, Lockwood CJ, Alvarez M, Plecas D, Chitkara U, Berkowitz RL. The severely anemic and hydropic isoimmune fetus: Changes in fetal hematocrit associated with intrauterine death. Obstet Gynecol 1992;79:390-3.
68. Selbing A, Stangenberg M, Westgren M, Rahman F. Intrauterine intravascular transfusions in fetal erythroblastosis: The influence of net transfusion volume on fetal survival. Acta Obstet Gynecol Scand 1993;72:20-3.
69. Halitsky V, Krumholz BA. Estimation of red cell volume requirements for intrauterine transfusion. Obstet Gynecol 1968;31:543-50.
70. MacGregor SN, Socol ML, Pielet BW, Sholl JS, Silver RK. Prediction of hematocrit decline after intravascular fetal transfusion. Am J Obstet Gynecol 1989;161:1491-3.
71. Liggins GC. Fetal transfusion by the impaling technique. Obstet Gynecol 1966;27:617-21.
72. Moise KJ, Carpenter RJ, Deter RL, Kirshon B, Diaz SF. The use of fetal neuromuscular blockade during intrauterine procedures. Am J Obstet Gynecol 1987;157:874-9.
73. Copel JA, Grannum PA, Harrison D, Hobbins JC. The use of intravenous pancuronium bromide to produce fetal paralysis during intravascular transfusion. Am J Obstet Gynecol 1988;158: 170-1.
74. Moise KJ, Deter RL, Kirshon B, Adam K, Patton DE, Carpenter RJ. Intravenous pancuronium bromide for fetal neuromuscular blockade during intrauterine transfusion for red-cell alloimmunization. Obstet Gynecol 1989;74:905-8.
75. Menticoglou SM, Harman CR, Manning FA, Bowman JM. Intraperitoneal fetal transfusion: Paralysis inhibits red cell absorption. Fetal Ther 1987;2:154-9.
76. Bernstein HH, Chitkara U, Plosker H, Gettes M, Berkowitz RL. Use of atracurium besylate to arrest fetal activity during intrauterine intravascular transfusions. Obstet Gynecol 1988;72:813-6.
77. Daffos F, Forestier F, Mac Aleese J, Aufrant C, Mandelbrot R, Cabanis EA, et al. Fetal curarization for prenatal magnetic resonance imaging. Prenat Diagn 1988;8:312-4.
78. Leveque C, Murat I, Toubas F, Poissonnier M-H, Brossard Y, Saint-Maurice C. Fetal neuromuscular blockade with vecuronium bromide: Studies during intravascular intrauterine transfusion in isoimmunized pregnancies. Anesthesiology 1992;76:642-4.
79. Pielet BW, Socol ML, MacGregor SN, Dooley SL, Minogue J. Fetal heart rate changes after fetal intravascular treatment with pancuronium bromide. Am J Obstet Gynecol 1988;159:640-3.
80. Moise KJ, Belfort MA, Saade GR, Van den Veyver IB, Carpenter RJ. Intrauterine transfusion for rhesus alloimmunization: A review of current methods. Video J Col Flow Imag 1992;2:36-46.
81. Bowman JM. Maternal alloimmunization and fetal hemolytic disease. In: Reece EA, Hobbins JC, Mahoney MJ, Petrie RH, eds. Medicine of the fetus and mother. Philadelphia: JB Lippincott, 1992:1152-82.
82. Steinfeld JD, Samuels P, Bulley MA, Cohen AW, Goodman DBP, Senior MB. The utility of the TDx test in the assessment of fetal lung maturity. Obstet Gynecol 1992;79:460-4.
83. Tait JF, Franklin RW, Simpson JB, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. I. Development of the assay procedure. Clin Chem 1986;32:248-54.
84. Weiner CP, Wenstrom KD, Sipes SL, Williamson RA. Risk factors for cordocentesis and fetal intravascular transfusion. Am J Obstet Gynecol 1991;165:1020-5.
85. Vietor HE, Kanhai HHH, Brand A. Induction of additional red cell alloantibodies after intrauterine transfusions. Transfusion 1994;34:970-4.
86. Gonsulin WJ, Moise KJ, Milam JD, Sala JD, Weber VW, Carpenter RJ. Serial maternal blood donations for intrauterine transfusion. Obstet Gynecol 1990;75:158-62.
87. Galligan BR, Cairns R, Schifano JV, Selbing A, Bernvil SS. Preparation of packed red cells suitable for intravascular transfusion in utero. Transfusion 1989;29:179-81.
88. Thorp JA, Plapp FV, Cohen GR, Yeast JD, O'Kell RT, Stephenson S. Hyperkalemia after irradiation of packed red blood cells: Possible effects with intravascular fetal transfusion. Am J Obstet Gynecol 1990;163:607-9.
89. Hashimoto B, Filly RA, Callen PW, Parer JT. Absorption of fetal intraperitoneal blood after intrauterine transfusion. J Ultrasound Med 1987;6:421-3.
90. Montague ACW, Holzman GB. The absorption rate of blood from the peritoneal cavity by the fetus. Am J Obstet Gynecol 1966;94: 282-3.
91. Hutchinson DL, Turner JH, Schlesinger ER. Persistence of donor cells in neonates after fetal and exchange transfusion. Am J Obstet Gynecol 1971;109:281-4.
92. Jones HM, Linch DC, Nicolaides K, Rodeck CH. Survival of transfused adult cells in the fetus. Fetal Ther 1986;1:193-5.
93. Pattison N, Roberts A. The management of severe erythroblastosis fetalis by fetal transfusion: Survival of transfused adult erythrocytes in the fetus. Obstet Gynecol 1989;74:901-4.
94. Chaim W, Mares AJ, Leiberman J, Cohen A. Omental herniation: An unusual fetal complication of intrauterine transfusion. Obstet Gynecol 1976;47:621-2.
95. Cassady G, Barnett R, Ceballos R. Dangers of fetal transfusion: Importance of placental location. Am J Obstet Gynecol 1971;110: 672-3.
96. Goodlin RC. Intrauterine transfusion complicated by amnionitis and maternal peritonitis: Report of a case. Obstet Gynecol 1965; 26:803.
97. Mandelbaum B, Brough AJ. Hepatitis following multiple intrauterine transfusions: Report of a case. Obstet Gynecol 1967;30: 188-91.
98. Seeds JW, Bowes WA, Chescheir NC. Echogenic venous turbulence is a critical feature of successful intravascular intrauterine transfusion. Obstet Gynecol 1989;73:488-90.
99. Evans DGR, Lyon AJ. Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion. Eur J Pediatr 1991;150: 780-1.
100. Parer JT. Severe Rh isoimmunization - Current methods of in utero diagnosis and treatment. Am J Obstet Gynecol 1988;158: 1323-9.
101. Nicolaides KH, Thorpe-Beeston JG, Salvesen DR, Snijders RJM. Fetal blood transfusion by cordocentesis. In: Chervenak FA, Isaacson GC, Campbell S, eds. Ultrasound in obstetrics and gynecology. Vol. 2. Boston: Little, Brown, 1993:1315-20.
102. Moise KJ, Carpenter RJ. Increased severity of fetal hemolytic disease with known rhesus alloimmunization after first-trimester transcervical chorionic villus biopsy. Fetal Diagn Ther 1990;5: 76-8.
103. Nicolini U, Kochenour NK, Greco P, Letsky EA, Johnson RD, Contreras M, et al. Consequences of fetomaternal haemorrhage after intrauterine transfusion. BMJ 1988;297:1379-81.
104. Nicolini U, Talbert DG, Fisk NM, Rodeck CH. Pathophysiology of pressure changes during intrauterine transfusion. Am J Obstet Gynecol 1989;160:1139-45.
105. Moise KJ, Mari G, Fisher DJ, Huhta JC, Cano LE, Carpenter RJ. Acute fetal hemodynamic alterations after intrauterine transfusion for treatment of severe red blood cell alloimmunization. Am J Obstet Gynecol 1990;163:776-84.
106. Warren PS, Gill RW, Fisher CC. Doppler flow studies in rhesus isoimmunization. Semin Perinatol 1987;11:375-8.
107. Rizzo G, Nicolaides KH, Arduini D, Campbell S. Effects of intravascular fetal blood transfusion on fetal intracaidiac Doppler velocity waveforms. Am J Obstet Gynecol 1990;163:1231-8.
108. Copel JA, Grannum PA, Green JJ, Belanger K, Hanna N, Jaffe CC, et al. Fetal cardiac output in the isoimmunized pregnancy: A pulsed Doppler-echocardiographic study of patients undergoing intravascular intrauterine transfusion. Am J Obstet Gynecol 1989; 161:361-5.
109. Mari G, Moise KJ, Deter RL, Carpenter RJ. Flow velocity wave-forms of the umbilical and cerebral arteries before and after intravascular transfusion. Obstet Gynecol 1990;75:584-9.
110. Mari G, Moise KJ, Deter RL, Kirshon B, Stefos T, Carpenter RJ. Flow velocity waveforms of the vascular system in the anemic fetus before and after intravascular transfusion for severe red blood cell alloimmunization. Am J Obstet Gynecol 1990;162: 1060-4.
111. Weiner CP, Robillard JE. Effect of acute intravascular volume expansion on human fetal prostaglandin concentrations. Am J Obstet Gynecol 1989;161:1494-7.
112. Kingdom JCP, Ryan G, Whittle MJ, McNay MB, Bowman AW, Doyle J, et al. Atrial natriuretic peptide: A vasodilator of the fetoplacental circulation? Am J Obstet Gynecol 1991;165:791-800.
113. Panos MZ, Nicolaides KH, Anderson JV, Economides DL, Rees L, Williams R. Plasma atrial natriuretic peptide in human fetus: Response to intravascular blood transfusion. Am J Obstet Gynecol 1989;161:357-61.
114. Robillard JE, Weiner C. Atrial natriuretic factor in the human fetus: Effect of volume expansion. J Pediatr 1988;113:552-5.
115. Weiner CP. Nonhematologic effects of intravascular transfusion on the human fetus. Semin Perinatol 1989;13:338-41.
116. Weiner CP, Smith F, Robillard JE. Arginine vasopressin and acute, intravascular volume expansion in the human fetus. Fetal Ther 1989;4:69-72.
117. Nicolini U, Santolaya J, Fisk NM, Hubinont C, Kochenour NK, Greco P, et al. Changes in fetal acid base status during intravascular transfusion. Arch Dis Child 1988;63:710-4.
118. Soothill PW, Nicolaides KH, Rodeck CH, Bellingham AJ. The effect of replacing fetal hemoglobin with adult hemoglobin on blood gas and acid-base parameters in human fetuses. Am J Obstet Gynecol 1988;158:66-9.
119. Soothill PW, Lestas AN, Nicolaides KH, Rodeck CH, Bellingham AJ. 2,3-Diphosphoglycerate in normal, anaemic and transfused human fetuses. Clin Sci 1988;74:527-30.
120. Socol ML, Dooley SL, Ney JA, Minogue JP, Millard DD, Ogata ES. Absence of hyperinsulinemia in isoimmunized fetuses treated with intravascular transfusion. Am J Obstet Gynecol 1991;165: 1737-40.
121. Nasrat HA, Nicolini U, Nicolaidis P, Letsky EA, Gau G, Rodeck CH. The effect of intrauterine intravascular blood transfusion on iron metabolism in fetuses with Rh alloimmunization. Obstet Gynecol 1991:77:558-62.
122. Lasker MR, Eddleman K, Toor AH. Neonatal hepatitis and excessive hepatic iron deposition following intrauterine blood transfusion. Am J Perinatol 1995;12:14-7.
123. Rodeck CH, Santolaya J, Nicolini U. The fetus with immune hydrops. In: Harrison MR, Golbus MS, Filly RA, eds. The unborn patient: Prenatal diagnosis and treatment. 2nd ed. Philadelphia: WB Saunders, 1991:215-27.
124. Weiner CP, Williamson RA, Wenstrom KD, Sipes SL, Widness JA, Grant SS, et al. Management of fetal hemolytic disease by cordocentesis: II. Outcome of treatment. Am J Obstet Gynecol 1991;165:1302-7.
125. Lemery D, Urbain M-F, Micorek J-C, Jacquetin B. Fetal umbilical cord catheterization under ultrasound guidance. Fetal Ther 1988; 3:37-43.
126. Lemery D, Urbain MF, VanLieferinghen P, Micorek JC, Jacquetin B. Intra-uterine exchange transfusion under ultrasound guidance. Eur J Obstet Gynecol Reprod Biol 1989;33:161-8.
127. Poissonnier M-H, Brossard Y, Demedeiros N, Vassileva J, Parnet F, Larsen M, et al. Two hundred intrauterine exchange transfusions in severe blood incompatibilities. Am J Obstet Gynecol 1989;161:709-13.
128. Ronkin S, Chayen B, Wapner RJ, Blocklinger A, Davis G, Roberts N, et al. Intravascular exchange and bolus transfusion in the severely isoimmunized fetus. Am J Obstet Gynecol 1989;160:407-11.
129. Barss VA, Benacerraf BR, Frigoletto FD, Greene MF, Penso C, Saltzman DH, et al. Management of isoimmunized pregnancy by use of intravascular techniques. Am J Obstet Gynecol 1988;159: 932-7.
130. Barss VA, Benacerraf BR, Greene MF, Frigoletto FD. Use of a small-gauge needle for intrauterine fetal transfusions. Am J Obstet Gynecol 1986;155:1057-8.
131. Grannum PAT, Copel JA, Moya FR, Scioscia AL, Robert JA, Winn HN, et al. The reversal of hydrops fetalis by intravascular intrauterine transfusion in severe isoimmune fetal anemia. Am J Obstet Gynecol 1988;158:914-9.
132. Orsini LF, Pilu G, Calderoni P, Zucchini S, Tripoli N, Pittalis MC, et al. Intravascular intrauterine transfusion for severe erythroblastosis fetalis using different techniques. Fetal Ther 1988;3:50-9.
133. Socol ML, MacGregor SN, Pielet BW, Tamura RK, Sabbagha RE. Percutaneous umbilical transfusion in severe rhesus isoimmunization: Resolution of fetal hydrops. Am J Obstet Gynecol 1987; 157:1369-75.
134. Berkowitz RL, Chitkara U, Wilkins IA, Lynch L, Plosker H, Bernstein HH. Intravascular monitoring and management of erythroblastosis fetalis. Am J Obstet Gynecol 1988;158:783-95.
135. Doyle LW, Cauchi M, Ch. de Crespigny L, Robinson H, Barrie J, Yong J, et al. Fetal intravascular transfusion for severe erythroblastosis: Effects on haematology and survival. Aust N Z J Obstet Gynaecol 1986;26:192-5.
136. Nicolaides KH, Soothill PW, Rodeck CH, Clewell W. Rh disease: Intravascular fetal blood transfusion by cordocentesis. Fetal Ther 1986;1:185-92.
137. Altmann P, Bruce JEF, Karnicki J. The influence of intrauterine transfusion upon birthweight in rhesus hemolytic disease. Eur J Obstet Gynecol Reprod Biol 1975;5:247-50.
138. Binks AS, Lind T, McNay RA. Effects of rhesus haemolytic disease upon birthweight. J Obstet Gynaecol Br Commw 1973;80:301-4.
139. Roberts A, Grannum P, Belanger K, Pattison N, Hobbins J. Fetal growth and birthweight in isoimmunized pregnancies after intravenous intrauterine transfusion. Fetal Diagn Ther 1993;8:407-11.
140. Utter GO, Socol ML, Dooley SL, MacGregor SN, Millard DD. Is intrauterine transfusion associated with diminished fetal growth? Am J Obstet Gynecol 1990;163:1781-4.
141. Doyle LW, Kelly EA, Rickards AL, Ford GW, Callanan C. Sensorineural outcome at 2 years for survivors of erythroblastosis treated with fetal intravascular transfusions. Obstet Gynecol 1993;81:931-5.
142. Hardyment AF, Salvador HS, Towell ME, Carpenter CW, Jan JE, Tingle AJ. Follow-up of intrauterine transfused surviving children. Am J Obstet Gynecol 1979;133:235-41.
143. Oh W, Arbit J, Blonsky ER, Cassell S. Neurologic and psychometric follow-up study of Rh-erythroblastotic infants requiring intrauterine blood transfusion. Am J Obstet Gynecol 1971;110:330-5.
144. Stewart G, Day RE, Del Priore C, Whittle MJ, Turner TL, Holland BM. Developmental outcome after intravascular intrauterine transfusion for rhesus haemolytic disease. Arch Dis Child 1994; 70:F52-3.
145. White CA, Coplerud CP, Kisker CT, Stehbens JA, Kitchell M, Taylor JC. Intrauterine fetal transfusion, 1965-1976, with an assessment of the surviving children. Am J Obstet Gynecol 1978;130:933-42.
146. Turner JH, Hutchinson DL, Hayashi TT, Petricciani JC, Germanowski J. Fetal and maternal risks associated with intrauterine transfusion procedures. Am J Obstet Gynecol 1975;123:251-6.
147. Knobbe T, Meier P, Wenar C, Cordero L. Psychological development of children who received intrauterine transfusions. Am J Obstet Gynecol 1979;133:877-9.
148. Lozinska D. The impact of intrauterine transfusions on morphological picture of red cells in Rh incompatibility. Arch Immunol Ther Exp (Warsz) 1987;35:775-9.
149. Saade GR, Moise KJ, Belfort MA, Hesketh DE, Carpenter RJ. Fetal and neonatal hematologic parameters in red cell alloimmunization: Predicting the need for late neonatal transfusions. Fetal Diagn Ther 1993;8:161-4.
150. Thorp JA, O'Connor T, Callenbach J, Cohen GR, Yeast JD, Albin J, et al. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease. Am J Obstet Gynecol 1991;165:79-81.
151. Koenig JM, Ashton RD, DeVore GR, Christensen RD. Late hypogenerative anemia in Rh hemolytic disease. J Pediatr 1989;115: 315-8.
152. Millard DD, Gidding SS, Socol ML, MacGregor SN, Dooley SL, Ney JA, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990;117:447-54.
153. Scaradavou A, Inglis S, Peterson P, Dunne J, Chervenak F, Bussel J. Suppression of erythroblastosis by intrauterine transfusions in hemolytic disease of the newborn: Use of erythropoietin to treat the late anemia. J Pediatr 1993;123:279-84.
154. Chitkara U, Bussel J, Alvarez M, Lynch L, Meisel RL, Berkowitz RL. High-dose intravenous gamma globulin: Does it have a role in the treatment of severe erythroblastosis fetalis? Obstet Gynecol 1990;76:703-8.
155. Gold WR, Queenan JT, Woody J, Sacher RA. Oral desensitization in Rh disease. Am J Obstet Gynecol 1983;146:980-1.
156. Graham-Pole J, Barr W, Willoughby MLN. Continuous-flow plasmapheresis in management of severe rhesus disease. BMJ 1977;1:1185-8.
157. Gusdon JP, Witherow C. Possible ameliorating effects of erythroblastosis by promethazine hydrochloride. Am J Obstet Gynecol 1973;117:1101-8.
158. Le Van Kim C, Mouro I, Cherif-Zahar B, Raynal V, Cherrier C, Cartron JP, et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A 1992;89:10925-9.
159. Spence WC, Maddalena A, Demers DB, Bick DP. Molecular analysis of the RhD genotype in fetuses at risk for RhD hemolytic disease. Obstet Gynecol 1995;85:296-8.
160. Van den Veyver IB, Chong SS, Cota J, Bennett PR, Fisk NM, Handyside AH, et al. Single-cell analysis of the RhD blood type for use in preimplantation diagnosis in the prevention of severe hemolytic disease of the newborn. Am J Obstet Gynecol 1995;172: 533-40.
161. Moise KJ, Rodkey LS, Saade G, Gei A, Dure M, Graham A, et al. An animal model for hemolytic disease of the fetus and newborn: I. Alloimmunization techniques. Am J Obstet Gynecol 1995;173: 51-5.